KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$0.1.

  • LifeMD's EPS (Basic) rose 2307.69% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.22, marking a year-over-year increase of 6507.94%. This contributed to the annual value of -$0.6 for FY2024, which is 1487.55% up from last year.
  • Latest data reveals that LifeMD reported EPS (Basic) of -$0.1 as of Q3 2025, which was up 2307.69% from -$0.05 recorded in Q2 2025.
  • In the past 5 years, LifeMD's EPS (Basic) registered a high of -$0.02 during Q1 2025, and its lowest value of -$0.7 during Q4 2021.
  • Its 5-year average for EPS (Basic) is -$0.29, with a median of -$0.2 in 2023.
  • As far as peak fluctuations go, LifeMD's EPS (Basic) tumbled by 13703.7% in 2021, and later skyrocketed by 8828.25% in 2025.
  • LifeMD's EPS (Basic) (Quarter) stood at -$0.7 in 2021, then surged by 41.61% to -$0.41 in 2022, then skyrocketed by 67.6% to -$0.13 in 2023, then fell by 4.33% to -$0.14 in 2024, then increased by 27.92% to -$0.1 in 2025.
  • Its EPS (Basic) was -$0.1 in Q3 2025, compared to -$0.05 in Q2 2025 and -$0.02 in Q1 2025.